20 profitable U.S. companies Paid No Corporate Income Tax Last Quarter
Author: |August 20, 2014
Corporate taxation has become an important issue in the U.S., as budget deficits loom and an important election approaches. Many U.S. companies have said that high corporate income tax is onerous and reduces their ability to compete globally.
20 profitable U.S. companies Paid No Corporate Income Tax Last Quarter
Corporate taxation has become an important issue in the U.S., as budget deficits loom and an important election approaches. Many U.S. companies have said that high corporate income tax is onerous and reduces their ability to compete globally.
According to USA Today analysis of S&P Capital IQ data, however, there were at least 20 companies in the Standard & Poor’s 500 that reported paying an effective tax rate of 0 percent or lower for the second quarter of 2014. To be included in the analysis, the companies had to report positive earnings, including unusual items, before taxes.
One such company was drug-producing giant Merck, which had a negative effective tax rate of 7.5 percent for the second quarter, according to USA Today. In other words, taxpayers gave the company the equivalent of 7.5 percent of its quarterly profits in tax credits. Merck’s pre-tax income rose 52 percent during the quarter, coming to $1.9 billion.
This anomalous tax rate was attributed to the “beneficial impact of foreign earnings” in the company’s filing, but Merck also got a significant one-time tax benefit from an option exercise that involved AstraZeneca’s purchase of its interest in a partnership, the news source explained. AstraZeneca has also been under public scrutiny with regards to corporate tax practices.
President Barack Obama and other liberals have been making corporate taxation a major issue ahead of the 2014 midterm elections. Both sides of Congress agree that tax code reform is necessary, but many analysts agree that the political deadlock will prevent anything from happening before the elections determine the shape of the next two years.
As tax attorneys for Scarinci Hollenbeck, a regional business law firm with offices in New York, New Jersey, and Washington D.C., James F. McDonough and I are acclimated with corporate culture and the goings-on of corporations regarding income taxes. Check out some of latest post on this hot-button topic:
- REITs & The Corporate Tax Base
- U.S. Corporate Tax Outlook Fueling Inversion Deals
- Corporate Tax Break Back In Senate Package
- NY Budget Ends Corporate Income Tax For Manufacturers
- What Corporate Inversions Are Telling Us (And What Washington Refuses To Hear)
- International Tax Trends
20 profitable U.S. companies Paid No Corporate Income Tax Last Quarter
![Does an S-corp Make Sense for your New Jersey Business?](https://res.cloudinary.com/scarinci-hollenbeck/images/f_auto,q_auto/v1642548395/wp.scarincihollenbeck/S-Corp-New-Jersey-Business/S-Corp-New-Jersey-Business.jpg?_i=AA 750w, https://res.cloudinary.com/scarinci-hollenbeck/images/w_300,h_140,c_scale/f_auto,q_auto/v1642548395/wp.scarincihollenbeck/S-Corp-New-Jersey-Business/S-Corp-New-Jersey-Business.jpg?_i=AA 300w, https://res.cloudinary.com/scarinci-hollenbeck/images/w_150,h_70,c_scale/f_auto,q_auto/v1642548395/wp.scarincihollenbeck/S-Corp-New-Jersey-Business/S-Corp-New-Jersey-Business.jpg?_i=AA 150w)
According to USA Today analysis of S&P Capital IQ data, however, there were at least 20 companies in the Standard & Poor’s 500 that reported paying an effective tax rate of 0 percent or lower for the second quarter of 2014. To be included in the analysis, the companies had to report positive earnings, including unusual items, before taxes.
One such company was drug-producing giant Merck, which had a negative effective tax rate of 7.5 percent for the second quarter, according to USA Today. In other words, taxpayers gave the company the equivalent of 7.5 percent of its quarterly profits in tax credits. Merck’s pre-tax income rose 52 percent during the quarter, coming to $1.9 billion.
This anomalous tax rate was attributed to the “beneficial impact of foreign earnings” in the company’s filing, but Merck also got a significant one-time tax benefit from an option exercise that involved AstraZeneca’s purchase of its interest in a partnership, the news source explained. AstraZeneca has also been under public scrutiny with regards to corporate tax practices.
President Barack Obama and other liberals have been making corporate taxation a major issue ahead of the 2014 midterm elections. Both sides of Congress agree that tax code reform is necessary, but many analysts agree that the political deadlock will prevent anything from happening before the elections determine the shape of the next two years.
As tax attorneys for Scarinci Hollenbeck, a regional business law firm with offices in New York, New Jersey, and Washington D.C., James F. McDonough and I are acclimated with corporate culture and the goings-on of corporations regarding income taxes. Check out some of latest post on this hot-button topic:
- REITs & The Corporate Tax Base
- U.S. Corporate Tax Outlook Fueling Inversion Deals
- Corporate Tax Break Back In Senate Package
- NY Budget Ends Corporate Income Tax For Manufacturers
- What Corporate Inversions Are Telling Us (And What Washington Refuses To Hear)
- International Tax Trends
Firm News & Press Releases
Bloomberg Law Podcast Discusses Significant IP Victory with Ron Bienstock
Scarinci Hollenbeck Attorneys Recognized as 2025 Best Lawyers in America®
New Jersey Environmental Attorneys Secure Victory on Behalf of Municipality of Princeton
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.